Paradigm4 provides technology to support decision making and discovery from multidimensional data sets. Their platform and apps help scientists gain insights from varied types of public and private data sets using an intuitive technology setup.
We worked with Paradigm4 to rebrand in a way that describes their value in scientific discovery. First we worked to understand their technology, then organized the content and created visual supports to show how the plaform and apps work together to create a user-friendly environment for discovery. We created the tagline “Multidimensional Insights” and the corresponding graphic — which includes accurate data visualizations — to reinforce the varied types of data that can be cross-referenced on their platform.
Infographics and icons lead the viewer through the site and support key messages.
We worked with Caraway Therapeutics to rename and rebrand the company from Rheostat. Caraway is pursuing novel approaches to treat debilitating neurodegenerative diseases by preserving neurons. It is a leader in the cutting-edge science of activating cellular recycling processes to clear toxic materials and defective cellular components. The name Caraway implies the carrying away and clearing of defective cellular material. The tagline “Clearing Away Neurodegenerative Disease” further underscores the approach. The logo is made of caraway seeds (used to clear breath and aid digestion) and is the basis for a set of custom icons to describe the science and the approach. The website is designed to grow as Caraway advances into the clinic, adds to the team, and develops new programs. Photography of the team and labs personalizes the site and ties the environment to the overall brand.
Acnos Pharma provides global clinical trial supply and general pharmaceutical sales in the EU. The company’s expert team and strategic location ensures that medicines are delivered in a streamlined and efficient manner.
We partnered with Acnos to rebrand the company in a way that focuses on service, expertise, and results. The new logo takes the Acnos “A” and turns it into a dynamic arrow pointing forward with colors that converge to a single point — reflecting all of the moving parts that coordinate within the company to deliver services. This idea then evolved into a set of visuals that use the arrow to show the primary process in the center (medicines deliver to patients) surrounded by all of the services (warehousing, consulting, bar codes, etc.) that contribute to the process. Coordinating infographics and icons provide additional items in the toolkit to highlight services and value.
Collegium Pharmaceutical is committed to being the leader in responsible pain management. For nearly two decades, Collegium has been focused on developing and commercializing new medicines for pain management that reflect their core values and commitment to people suffering from pain, healthcare providers, and communities.
We worked with Collegium to rebrand the company beginning with a new logo that communicates the “collegial” in Collegium. The logo tells the story of multiple parts working together to move pain management forward while bringing the “C” into the center. The logo and colors, combined with custom photography of Collegium’s people and environment build a site that tells the story of their mission, core values, and teamwork.
Talaris is developing a single-dose cell therapy that seeks to free organ transplant recipients of the burdens and toxicities of lifelong immunosuppression, without rejecting their transplanted organ. We began our engagement wih the name — Talaris is adapted from “talaria,” the winged sandals worn by Greek messenger god Hermes, which gave him protection. In a similar way, the facilitating cells central to the platform protect and deliver other immune cells to safety within the recipient patient. The logo is representative of the facilitating cells in combination with the patient and donor cells. Moving forward with the brand, we wanted to represent a wide variety of patients and underscore their experience with the tagline “Live your life. Beyond the transplant.” Custom infographics explain the process and communicate the strong clinical results already established for the therapy as the company moves forward into a phase 3 trial.
Anokion is focused on improving the treatment and outcomes of autoimmune disease with a proprietary antigen-specific immune tolerance technology. Starting with Anokion’s existing logo and palette, we created a new visual brand for their website and presentation; incorporating custom design elements, new photography of both their team and laboratories, and copy. These will give both investors and future employees a strong sense of where Anokion is going and what they have to offer. This robust website and visual brand will support the business as it matures into a full clinical stage company.
Avayle provides strategic planning, global procurement, supply forecasting, and project management for clinical trials that help increase efficiency and reduce costs. We began our project with a name that reflects their benefits to clients and patients — Avayle means to help or benefit in middle english. The company identity communicates the interconectedness and many aspects of supplying and planning clinical trials. Building upon that look for the website are a set of custom icons and photographic combination images that blend with the elements in the logo to create a unique and dynamic visual brand.
Ziopharm is developing the next generation of immuno-oncology medicines that target multiple types of cancers on two fronts — weaponizing the existing immune system and introducing new immune system elements. In addition, the company is targeting the cost and complexity of these therapies. We worked with Ziopharm to build a brand around this dual approach and to illustrate how the company’s technology works to combat cancer.
CARB-X is accelerating global antibacterial innovation by investing in the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria. Their projects represent the world’s largest pre-clinical and early development pipeline of antibiotics and other therapeutics, diagnostics, microbiome, vaccines, and devices. We partnered with CARB-X to create a brand that speaks to funders, scientists, and the general public. We updated their logo to be more legible, and to clearly define the organizations’s name. Setting up a plan for a robust website provided space for statistics, education on antibiotic resistance and overuse, resources, meetings, and a clear story about the organization’s value in supporting global health. Custom photos, icons, and infographics support their message and create the basis for a full organizational brand.